anti-Regenerating Islet-Derived Family, Member 4 (REG4) 抗体

Human Regenerating Islet-Derived Family, Member 4 (REG4) interaction partners

1. Our study demonstrated that Reg IV positively regulates the expression of SOX9 and is involved in tumor cell invasion and migration in gastric cancer.

2. Reg4 inhibited apoptosis through regulating MAPK/Erk/Bim signaling pathway and thereby enhanced the resistance of gastric cancer to 5-Fluorouracil.

3. Data indicate that REG4 tissue expression is a prognostic marker in subgroups of pancreatic ductal adenocarcinoma patients, and Serum REG4 level might be useful in differential diagnosis between pancreatic ductal adenocarcinoma and chronic pancreatitis.

4. REG4 promotes peritoneal metastasis of gastric cancer through GPR37 and triggers a positive feedback loop.

5. Study demonstrated that REG4, which is overexpressed in pancreatic ductal adenocarcinoma and secreted by cancer cells, promoted macrophage polarization to M2, through at least in part, activation of ERK1/2 and CREB.

6. REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis.

7. This study identifies REG4 as a potential serum biomarker for histotype-specific detection of mucinous ovarian cancer and suggests serum REG4 measurement as a non-invasive diagnostic tool for follow-up of patients with mucinous ovarian cancer.

8. aberrant REG4 expression plays an essential role in early ovarian carcinogenesis and is closely linked to mucinous ovarian tumors, differentiation and adverse prognosis of ovarian cancer by modulating proliferation, apoptosis, migration and invasion.

9. REG4 expression associated with favorable clinicopathological parameters and with higher overall survival from non-mucinous

10. The Reg IV may be involved in the finetuning of functions exerted by the neuroendocrine cells in the GI-tract.

11. Colorectal tumor patients with Reg4- and MMP-7-positive tumors had extremely poor overall survival.

12. High expression of REG4 is associated with poor therapeutic response, adverse outcome and an aggressive phenotype in rectal cancer patients treated with neoadjuvant chemoradiotherapy.

13. miR-24 functions as a novel tumor suppressor in gastric cancer, and the anti-oncogenic activity may involve its inhibition of the target gene REG4.

14. REG4 expression is common in mucinous borderline ovarian tumors of the intestinal type as it is absent in the endocervical-like form tumors.

15. the combination of VEGF-C and Reg IV may be a promising factor for clinical staging to supplement the classical TNM classification system.

16. the stemness properties of control mammospheres and RegIV knockdown mammospheres were compared by tumourigenicity assay in vivo and plate colony formation assay in vitro.

17. Reg4-induced mitogenesis involves Akt-GSK3beta-beta-Catenin-TCF-4 signaling in human colorectal cancer.

18. Immunohistochemistry against known cell-type markers on serial sections has localised the expression of REGs to metaplastic Paneth cells (REG1A, REG1B and REG3A) and enteroendocrine cells (REG4), with a marked expansion of expression during inflammation.

19. CDX2 protein directly regulates Reg IV expression in gastric cancer

20. RegIV may play an important role in the intrinsic resistance of gastric cancer cells to 5-FU.

Mouse (Murine) Regenerating Islet-Derived Family, Member 4 (REG4) interaction partners

1. sorted Reg4(+) DCS cells promote organoid formation of single Lgr5(+) colon stem cells. DCS cells can be massively produced from Lgr5(+) colon stem cells in vitro by combined Notch inhibition and Wnt activation

2. data suggest that Reg4 may protect against acinar cell necrosis in experimental pancreatitis by enhancing the expression of Bcl-2 and Bcl-xL via activation of the EGFR/Akt signalling pathway.

3. Reg IV as an important modulator of gastrointestinal cell susceptibility to irradiation; hence, it is a potential target for adjunctive treatments for human colorectal cancer and other gastrointestinal malignancies.

4. reg4 is amplified in the early stages of pancreatic cancer development

5. Cloning and characterization of human REG4/RELP, in addition to cloning of mouse Reg4.